NeurogesX (NGSX)
NeurogesX Beneish M-Score: -2.241
View NGSX Beneish M-Score with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
NGSX Beneish M-Score Rankings
| Overall | 23rd percentile | 2900 of 3770 |
| Sector | 28th percentile | 246 of 342 in Healthcare |
| Industry | 45th percentile | 12 of 22 in Drug Manufacturers - Other |
NGSX Beneish M-Score Range, Past 5 Years
| Minimum | -2.241 | Dec 2011 |
| Maximum | -2.241 | Dec 2011 |
| Average | -2.241 |
About Beneish M Score
The Beneish M Score helps to uncover companies who are likely to be manipulating their reported earnings. Companies with a higher score are more likely to be manipulators. This is a probabilistic model, so it will not detect manipulators with 100% accuracy.
The best cut-off point depends on the costs mistakenly classifying in one of two ways:
1) Classifying firm that is manipulating earnings as a non-manipulator (Type I error), and
2) Classifying a firm as a manipulator when it actually was not manipulating (Type II Error).
Here are optimal cut-offs according to Beneish, presented as the score followed by the cost of Type I error relative to cost of Type II error):
M Score HTML Table:
| Score | Relative Error Costs (Type I:Type II) |
|---|---|
| M Score > -1.49 | (10:1) | M Score > -1.78 | (20:1) | M Score > -1.89 | (40+:1) |
Beneish excluded financial institutions from his sample when calculating the M-Score, so extreme care should be taken when looking at M-Scores of financial firms - their business models are different from the manufacturing and other service firms that Beneish used in his study.
If you want more details, here is the original Beneish M Score Paper, or you can learn about our calculation by clicking "Learn More" below.
Learn More
You may also be interested in these NGSX related companies
NGSX News
@gofigure $PPHM $NGSX $GALE short term yes, but Long term no they are not done! All have huge potential for big gains!
about 31 days ago by BiopharmaPro
about 31 days ago by BiopharmaPro
NeurogesX to Hold Conference Call to Discuss First Quarter 2012 Results
Apr 27, 9:00AM GlobeNewswire
Apr 27, 9:00AM GlobeNewswire
$ngsx Hearings are typically scheduled 30 to 45 days from the company's request
about 35 days ago by bood747
about 35 days ago by bood747
@rickz $ngsx supposed to delist tomorrow.I cant find any news on whether thye got a hearing or not.any info?
about 36 days ago by bood747
about 36 days ago by bood747
NeurogesX Receives Determination Letter From NASDAQ; Not Regaining Compliance
Apr 20, 4:06PM Benzinga
Apr 20, 4:06PM Benzinga
No i'm not kidding, 3/4 portfolio in $OCZ 1/4 BIT:ISP $PPHM $NGSX $GALE I'm all IN
about 41 days ago by micheleciani
about 41 days ago by micheleciani
$NGSX performing well today, if will go OUT in the upper part of the triangle in 1 day we go pair http://chart.ly/eutswy8
about 41 days ago by micheleciani
about 41 days ago by micheleciani
NeurogesX (NGSX) Gets FDA Acceptance for End-of-Phase 2 Meeting for NGX-1998
Apr 11, 7:33AM Street Insider
Apr 11, 7:33AM Street Insider
Wedbush Upgrades NeurogesX, Inc. (NGSX) to Outperform; Restructuring Puts NGX-1998 Liquid Formulation On Center Stage
Mar 14, 1:50PM Street Insider
Mar 14, 1:50PM Street Insider
NeurogesX to Hold Conference Call to Discuss Fourth Quarter and Full Year 2011 Results
Feb 29, 8:30AM GlobeNewswire
Feb 29, 8:30AM GlobeNewswire
NeurogesX (NGSX) Confirms FDA Panel Did Not Recommend Approval of Qutenza
Feb 09, 5:47PM Street Insider
Feb 09, 5:47PM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| NGSX | 0.37 | +0.00 | +0.00% | 11.07M |
| NGPC | 6.71 | +0.03 | +0.45% | 144.49M |
| NGLS | 40.45 | -0.92 | -2.22% | 3.764B |
| NGG | 50.55 | -2.94 | -5.50% | 39.03B |
| NGB | 16.30 | +0.00 | +0.00% | |
| NFZ | 14.67 | +0.02 | +0.14% | |
| NFX | 30.56 | -1.58 | -4.92% | 4.346B |
| NFP | 13.19 | -0.12 | -0.90% | 536.26M |
| NFO | 31.54 | -0.56 | -1.73% | |
| NFLX | 67.34 | -2.10 | -3.02% | 3.848B |
